Do immunoglobulin receptor interactions play a role in CLL?
The problem of treating AML with CD123-targeting drugs
PHILEMON: a step closer to using MRD to guide treatment decisions in mantle cell lymphoma (MCL)?
What we can learn about treating CLL from research on other cancers
How combining an evolutionary perspective with genomic methods can advance CLL treatment